138 Publications (Page 4 of 6)
2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.Henry, N Lynn⋅Henry, Norah L⋅Rae, James⋅Rae, James M⋅Li, Lang⋅Li, Lang⋅Azzouz, Faouzi⋅Azzouz, Faouzi⋅Skaar, Todd C⋅Skaar, Todd C⋅Desta, Zereunesay⋅Desta, Zereunesay⋅Sikora, Matthew J⋅Sikora, Matthew J⋅Philips, Santosh⋅Philips, Santosh⋅Nguyen, Anne T⋅Nguyen, Anne T⋅Storniolo, Anna Maria⋅Storniolo, Anna M⋅Hayes, Daniel F⋅Hayes, Daniel F⋅Flockhart, David A⋅Flockhart, David A⋅Stearns, Vered and Stearns, VeredBreast cancer research and treatment, vol. 117, (no. 3), pp. 571-5, 2009/Oct.
| Journal Article
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.Miao, J⋅Jin, Y⋅Marunde, R L⋅Kim, S⋅Gorski, C J⋅Quinney, Sara K⋅Kim, S⋅Radovich, Milan⋅Quinney, S⋅Radovich, M⋅Li, L⋅Li, L⋅Hall, S D and Hall, S DThe pharmacogenomics journal, vol. 9, (no. 5), pp. 319-326, October 2009.
| Journal Article
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.Rae, James⋅Sikora, M J⋅Henry, Norah L⋅Li, L⋅Kim, S⋅Oesterreich, Steffi⋅Skaar, Todd C⋅Nguyen, A T⋅Desta, Zeruesenay⋅Storniolo, Anna M⋅Flockhart, David A⋅Hayes, Daniel F and Stearns, VeredThe pharmacogenomics journal, vol. 9, (no. 4), pp. 258-64, 2009/Aug.
| Journal Article
Differential gene expression profiling of esophageal adenocarcinoma.Hammoud, Zane T⋅Badve, Sunil S⋅Zhao, Qianqian⋅Li, Lang⋅Saxena, Romil⋅Thorat, Mangesh A⋅Morimiya, Akira⋅Rieger, Karen M and Kesler, Kenneth AThe Journal of thoracic and cardiovascular surgery, vol. 137, (no. 4), pp. 829-34, 2009/Apr.
| Journal Article
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapyOnitilo, Adedayo A⋅Mc Carty, Catherine A⋅Wilke, Russell⋅Glurich, Ingrid⋅Engel, Jessica M⋅Flockhart, David A⋅Nguyen, Anne⋅Li, Lang⋅Mi, Deming⋅Skaar, Todd and Jin, YanBreast cancer research and treatment., vol. 115, (no. 3), pp. 643-650, 2009.
| Journal Article
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashesSchneider, Bryan P⋅Radovich, Milan⋅Flockhart, David A⋅Carpenter, Janet S⋅Li, Lang⋅Robarge, Jason D⋅Storniolo, Anna M⋅Hancock, Bradley A⋅Skaar, Todd and Sledge, George WBreast Cancer Research and Treatment, vol. 116, (no. 3), pp. 543-9, Aug 2009.
| Journal Article
Literature mining on pharmacokinetics numerical data: a feasibility study.Wang, Zhiping⋅Kim, Seongho⋅Quinney, Sara K⋅Guo, Yingying⋅Hall, Stephen D⋅Rocha, Luis M and Li, LangJournal of biomedical informatics, vol. 42, (no. 4), pp. 726-35, 2009/Aug.
| Journal Article
Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group.Srinivasan, Balaji S⋅Chen, Jinbo⋅Cheng, Cheng⋅Conti, David V⋅Duan, Shiwei⋅Fridley, Brooke⋅Gu, Xiangjun⋅Haines, Jonathan L⋅Jorgenson, Eric⋅Kraja, Aldi T⋅Lasky-Su, Jessica⋅Li, Lang⋅Rodin, Andrei S⋅Wang, Dai⋅Province, Michael A and Ritchie, Marylyn DPharmacogenomics, vol. 10, (no. 2), pp. 243-51, 2009/Feb.
| Journal Article
Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.Haas, David M⋅Hebert, Mary F⋅Soldin, Offie P⋅Flockhart, David A⋅Madadi, Parvaz⋅Nocon, James J⋅Chambers, Christina D⋅Hankins, Gary D⋅Clark, Shannon⋅Wisner, Katherine L⋅Li, Lang⋅Renbarger, Jamie L and Learman, Lee AClinical and translational science, vol. 2, (no. 6), pp. 439-43, 2009/Dec.
| Journal Article
Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test.Desta, Zeruesenay⋅Modak, Anil⋅Nguyen, Phuong D⋅Lemler, Suzanne M⋅Kurogi, Yasuhisa⋅Li, Lang and Flockhart, David AThe Journal of pharmacology and experimental therapeutics, vol. 329, (no. 1), pp. 297-305, 2009/Apr.
| Journal Article
2008
A Bayesian Meta-Analysis on Published Sample Mean and Variance Pharmacokinetic Data with Application to Drug-Drug Interaction PredictionYu, Menggang⋅Kim, Seongho⋅Wang, Zhiping⋅Hall, Stephen D and Li, LangJournal of Biopharmaceutical Statistics, vol. 18, (no. 6), pp. 1063-1083, 2008.
| Journal Article
A hierarchical statistical model to assess the confidence of peptides and proteins inferred from tandem mass spectrometryShen, Changyu⋅Wang, Zhiping⋅Shankar, Ganesh⋅Zhang, Xiang and Li, LangBioinformatics, vol. 24, (no. 2), pp. 202-8, Jan 15, 2008.
| Journal Article
A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes.Li, Lang⋅Yu, Menggang⋅Jason, Robarge D⋅Shen, Changyu⋅Azzouz, Faouzi⋅Mc Leod, Howard L⋅Borges-Gonzales, Silvana⋅Nguyen, Anne⋅Skaar, Todd C⋅Desta, Zeruesenay⋅Sweeney, Christopher J and Flockhart, David AJournal of biopharmaceutical statistics, vol. 18, (no. 6), pp. 1150-77, 2008.
| Journal Article
A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technologyFeng, Weixing⋅Liu, Yunlong⋅Wu, Jiejun⋅Nephew, Ken⋅Huang, Tim H and Li, LangBMC Genomics, vol. 9, (no. Suppl 2), pp. S23-S23, 2008.
| Journal Article
A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technology.Feng, Weixing⋅Liu, Yunlong⋅Wu, Jiejun⋅Nephew, Ken⋅Huang, Tim H and Li, LangBMC genomics, vol. 9 Suppl 2, pp. S23, 2008.
| Journal Article
Association of polymorphisms of angiogenesis genes with breast cancerSchneider, Bryan P⋅Radovich, Milan⋅Sledge, George W⋅Robarge, Jason D⋅Li, Lang⋅Storniolo, Anna M⋅Lemler, Suzanne⋅Nguyen, Anne T⋅Hancock, Bradley A⋅Stout, Michael⋅Skaar, Todd and Flockhart, David ABreast Cancer Research and Treatment, vol. 111, (no. 1), pp. 157-63, Sep 2008.
| Journal Article
Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cellsLi, Meng⋅Paik, Hyun-il H⋅Balch, Curtis⋅Kim, Yoosung⋅Li, Lang⋅Huang, Tim H⋅Nephew, Ken and Kim, SunBioinformatics, vol. 24, (no. 16), pp. 1745-8, Aug 15, 2008.
| Journal Article
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.Ntukidem, N I⋅Nguyen, A T⋅Stearns, Vered⋅Rehman, M⋅Schott, A⋅Skaar, Todd C⋅Jin, Y⋅Blanche, P⋅Li, L⋅Lemler, S⋅Hayden, J⋅Krauss, Ronald M⋅Desta, Z⋅Flockhart, D A and Hayes, Daniel FClinical pharmacology and therapeutics, vol. 83, (no. 5), pp. 702-10, 2008/May.
| Journal Article
Identification of transcription factor and microRNA binding sites in responsible to fetal alcohol syndromeWang, Guohua⋅Wang, Xin⋅Wang, Yadong⋅Yang, Jack Y⋅Li, Lang⋅Nephew, Ken⋅Edenberg, Howard J⋅Zhou, Feng C and Liu, YunlongBMC Genomics, vol. 9, (no. Suppl 1), pp. S19-S19, 2008.
| Journal Article
Identification of transcription factor and microRNA binding sites in responsible to fetal alcohol syndrome.Wang, Guohua⋅Wang, Xin⋅Wang, Yadong⋅Yang, Jack Y⋅Li, Lang⋅Nephew, Ken⋅Edenberg, Howard J⋅Zhou, Feng C and Liu, YunlongBMC genomics, vol. 9 Suppl 1, pp. S19, 2008.
| Journal Article
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Henry, Norah L⋅Giles, Jon T⋅Ang, Dennis⋅Mohan, Monika⋅Dadabhoy, Dina⋅Robarge, Jason⋅Hayden, Jill⋅Lemler, Suzanne⋅Shahverdi, Karineh⋅Powers, Penny⋅Li, Lang⋅Flockhart, David A⋅Stearns, Vered⋅Hayes, Daniel F⋅Storniolo, Anna M and Clauw, Daniel JBreast cancer research and treatment, vol. 111, (no. 2), pp. 365-72, 2008/Sep.
| Journal Article
Using RNase sequence specificity to refine the identification of RNA-protein binding regionsWang, Xin⋅Wang, Xin⋅Wang, Guohua⋅Wang, Guohua⋅Shen, Changyu⋅Shen, Changyu⋅Li, Lang⋅Li, Lang⋅Wang, Xinguo⋅Wang, Xinguo⋅Mooney, Sean D⋅Mooney, Sean D⋅Edenberg, Howard J⋅Edenberg, Howard J⋅Sanford, Jeremy R⋅Sanford, Jeremy⋅Liu, Yunlong and Liu, YunlongBMC Genomics, vol. 9, (no. Suppl 1), pp. S17-S17, 2008.
| Journal Article
Using RNase sequence specificity to refine the identification of RNA-protein binding regions.Wang, Xin⋅Wang, Guohua⋅Shen, Changyu⋅Li, Lang⋅Wang, Xinguo⋅Mooney, Sean D⋅Edenberg, Howard J⋅Sanford, Jeremy and Liu, YunlongBMC genomics, vol. 9 Suppl 1, pp. S17, 2008.
| Journal Article
2007
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-[alpha]2b in patients with solid tumorsSchneider, Bryan⋅Schneider, Bryan⋅Fukunaga, Anna⋅Fukunaga, Anna⋅Murry, Daryl⋅Murry, Daryl⋅Yoder, Christy⋅Yoder, Christy⋅Fife, Karen⋅Fife, Karen⋅Foster, Anne⋅Foster, Anne⋅Rosenberg, Leslie⋅Rosenberg, Leslie⋅Kelich, Stephanie⋅Kelich, Stephanie⋅Li, Lang⋅Lang, Li⋅Sweeney, Christopher and Sweeney, ChristopherCancer Chemotherapy and Pharmacology, vol. 59, (no. 2), pp. 261, 20070201.
| Journal Article
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumorsSchneider, Bryan⋅Schneider, Bryan P⋅Fukunaga, Anna⋅Fukunaga, Anna⋅Murry, Daryl⋅Murry, Daryl J⋅Yoder, Christy⋅Yoder, Christy⋅Fife, Karen⋅Fife, Karen⋅Foster, Anne⋅Foster, Anne⋅Rosenberg, Leslie⋅Rosenberg, Leslie⋅Kelich, Stephanie⋅Kelich, Stephanie⋅Li, Lang⋅Li, Lang⋅Sweeney, Christopher and Sweeney, Christopher JCancer chemotherapy and pharmacology, vol. 59, (no. 2), pp. 261, 2007-Feb.
| Journal Article